A Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANB019 in Healthy Subjects and Psoriasis Patients.
A Double-Blinded, Randomized, Placebo-Controlled, Single AscendingDose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate theSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANB020in Healthy Subjects.
100 Clinical Results associated with AnaptysBio Pty Ltd.
0 Patents (Medical) associated with AnaptysBio Pty Ltd.
100 Deals associated with AnaptysBio Pty Ltd.
100 Translational Medicine associated with AnaptysBio Pty Ltd.